GlobalData on MSN12h
Japan’s MHLW approves CSL Behring’s Andembry to stop HAE attacks
CSL Behring KK has gained approval from Japan's Ministry of Health, Labour and Welfare (MHLW) to manufacture and market subcutaneous (SC) injection 200mg Andembry pens designed to prevent acute ...
PharmiWeb2d
U.S. FDA Accepts Gilead’s New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir—the company’s twice-yearly ...
Managed Healthcare Executive2d
FDA Accepts NDA for Gilead's New HIV Prevention Shot
Lenacapavir is a twice-yearly injectable medication designed to be used as pre-exposure prophylaxis (PrEP). The FDA is giving ...
News Day5d
Jobs lost and treatment stopped as USAid freeze hits HIV care in Zim
Gumisayi Bonzo, a director at Trans Smart Trust, an organisation offering HIV and Aids services to transgender and intersex ...
dvm3606d
Managing canine oral tumors
Several important steps should be taken and/or considered after the identification of an oral cavity lesion: Perform a ...